CHAPTER 52  INTRODUCTION TO NUCLEAR
                    MEDICINE

DAVID K. SHELTON

Introduction
Imaging Principles
Radiotherapy
An Approach to Image Interpretation
Section Overview

             INTRODUCTION                                                  IMAGING PRINCIPLES

Nuclear medicine encompasses both therapeutic and diagnos-        The basic principles of diagnostic nuclear radiology are simple
tic modalities that support practically every field of medical    to grasp, yet somehow seem to elude first-year residents as
endeavor. Despite changes in referral patterns and the advent     they are overwhelmed with information at the outset of their
of managed care, nuclear medicine studies remain among the        training. The concept of nuclear imaging is based on the exter-
most cost-effective for the diagnosis and management of a         nal detection and mapping (emission image) of the biodistri-
variety of diseases. Radiographic, ultrasonographic, and MR       bution of radiotracers that have been administered to a
studies provide high spatial resolution and important ana-        patient. The knowledge of the normal patterns of uptake, dis-
tomic or structural information from which pathologic pro-        tribution, and excretion permits us to make decisions concern-
cesses are inferred. On the other hand, nuclear medicine          ing the presence or absence of disease.
studies provide high functional resolution and provide physi-
ologic and functional information not otherwise available.            Sometimes a radionuclide or radioisotope of a naturally
Anatomic imaging can measure the dimensions of a spot, but        occurring element essential to normal biologic function (e.g.,
functional imaging can show whether it is active and whether      Iodine-123) or an analog (e.g., Technetium-99m Pertechne-
it is malignant or not (Fig. 52.1). With this being the decade    tate, Tc-99m-O4) is used without additional chemical altera-
for advancing functional imaging, many new, important tech-       tion (Fig. 53.3). More commonly, a radioactive isotope is
niques have become commonplace in the clinical environment.       combined with a physiologically "active" compound to cre-
PET-CT and now SPECT-CT have improved the sensitivity             ate a radiopharmaceutical which can be administered intra-
and specificity for neural, cardiac, and oncological imaging.     venously, orally, or via direct injection. Thus Tc-99m-O4 may
PET-CT has greatly improved patient throughput, tumor stag-       be combined with a diphosphonate compound for skeletal
ing, and evaluation of tumor response to therapy (Fig. 52.2).     imaging. If the same radioisotope is combined with an imino-
Molecular medicine and molecular imaging promise to bring         diacetic acid derivative, the biologic distribution reflected by
applications of genomics and protein messaging quickly into       the images will be that of a biliary scan. This simple concept
the clinical arena. We now have the ability to follow gene ther-  is the foundation for imaging the biodistribution of radiola-
apy as well as stem-cell therapy through their introduction       beled blood cells, monoclonal antibodies, peptides, and energy
into the patient. Lymphoscintigraphy is helping surgeons to       substrates such as glucose and fatty acids. If this unifying prin-
better stage melanoma and breast cancer and has significantly     ciple can be kept in mind while reading the various sections on
decreased patient morbidity following nodal staging proce-        nuclear imaging, the diverse number and types of studies may
dures. Hand-held probes allow better localization of sentinel     seem somewhat less bewildering.
nodes as well as of small difficult lesions identified on PET
FDG scans. New therapies include antibody therapy for lym-                     RADIOTHERAPY
phoma, and research is being advanced for breast cancer anti-
body therapy, I-131 MIBG and yttrium (Y-90)-labeled               Radiotherapy is an extremely important arm of nuclear medi-
octreotide.                                                       cine and is critical to several areas of clinical medicine. The
                                                                  distinguishing feature of therapeutic radioisotopes and radio-
    The material in this section is intended to provide an over-  pharmaceuticals is that they are particulate emitters, with beta
view of the specialty and at the same time serve as the basis of  emitters being utilized much more commonly than alpha emit-
review for those residents preparing for board examinations.      ters. Beta particles only travel a short distance through tissues,
The information should also be useful to those who may not        depositing most of their energy within a couple of millimeters.
practice nuclear medicine regularly or may not have done so       I-131 is utilized for benign thyroid conditions such as Graves'
recently.

1228
                                                                       Chapter 52: Introduction to Nuclear Medicine  1229

FIGURE 52.1. PET-CT Scan of Brain. PET scan of the brain with          FIGURE 52.3. Iodine-123 Thyroid Scan. The patient presented with
FDG is fused onto CT scan and shows increased FDG metabolic activ-     symptoms and laboratory findings of hyperthyroidism. The scan
ity (arrow), confirming the recurrence of glioblastoma after previous  shows diffuse, homogeneous enlargement and an increased uptake of
surgery and radiotherapy.                                              77%, consistent with Graves' disease. She was then successfully
                                                                       treated with oral Iodine-131.
FIGURE 52.2. Maximum Intensity Projection (MIP) Image From
Whole-Body PET FDG Scan. Whole-body PET CT scan was done for           disease, toxic adenoma, and Plummer disease or toxic multi-
initial staging in breast cancer patient and demonstrates multiple     modular goiter (Fig. 52.3). I-131 is also the primary treatment
areas of abnormal hypermetabolic foci, consistent with diffuse meta-   of choice for thyroid remnant ablation and metastatic thyroid
static breast cancer.                                                  cancer. I-131 MIBG and Y90 octreotide are under evaluation
                                                                       for treatment of metastatic neuroendocrine tumors as well.

                                                                           P-32 can be given intravenously for hematological disor-
                                                                       ders such as essential thrombocytosis, or in colloidal form for
                                                                       localized installation in arthritic joints for radiosynovectomy,
                                                                       in cystic tumors or into malignant fluid collections. Stron-
                                                                       tium-89 and Samarium-153 have proven effective in palliative
                                                                       pain management for patients with osteoblastic bone metas-
                                                                       tases. Radioimmunotherapy (RIT) with monoclonal antibod-
                                                                       ies is now being utilized for refractory lymphoma treatment
                                                                       with ibritumomab tiuxetan (Yttrium-90 Zevalin©) and tositu-
                                                                       momab (I-131 Bexxar©) (Fig. 52.4). RIT is also being studied
                                                                       for refractory metastatic breast cancer. A new form of radio-
                                                                       embolotherapy (RET) is being utilized in conjunction with
                                                                       interventional radiology. After careful planning and dosim-
                                                                       etry calculations, Y-90 microspheres are injected directly into
                                                                       selected hepatic arteries for treatment of unresectable hepato-
                                                                       cellular or for metastatic liver disease.

                                                                             AN APPROACH TO IMAGE
                                                                                   INTERPRETATION

                                                                       Obviously, a basic fund of anatomic, physiologic, and nuclear
                                                                       imaging knowledge is necessary in order to make intelligent
                                                                       diagnoses and differential diagnoses, based on nuclear medicine
                                                                       images. The suggested approach to image interpretation pro-
                                                                       vided here will make more sense after reading the remainder of
                                                                       the nuclear medicine section, and for the resident will be of
                                                                       greater value after the second or third nuclear medicine rotation.

                                                                           When preparing to discuss a case, it is first important to
                                                                       determine the radiopharmaceutical and therefore the type of
                                                                       study which may be as simple as reviewing the film margins
                                                                       or paperwork for textual information. It is poor form to ask,
                                                                       "What type of study is this?" when the information is readily
1230  Section Twelve: Nuclear Radiology

FIGURE 52.4. Indium-111 Zevalin© Antibody Diagnostic Scan.                Next, study the biodistribution of activity and anatomy in
Whole-body scan demonstrates normal biodistribution of the antibody   the images: Is there evidence of cardiac or great vessel blood
agent and multiple foci of increased uptake, consistent with known    pool activity? Is skeletal activity present? What organs or
B-cell lymphoma. The patient was then successfully treated with Y-90  structures are visualized? Are there obvious focal abnormali-
Zevalin© radioimmunotherapy with good clinical and CT response.       ties? From a knowledge of the biodistribution evident on the
                                                                      images and a reasonable assumption about the likely radio-
at hand. At the same time, one may also glean important infor-        isotope, one may make some conjecture as to the most likely
mation about the age and sex of the patient, the site of injec-       radiopharmaceutical in use.
tion, the temporal sequence when multiple images are present,
the type of images (planar or tomographic, static, or dynamic),           After determining the radiopharmaceutical and the type of
and patient orientation during imaging (right/left, oblique,          study, proceeding with the rest of the analysis is fairly straight-
posterior, upright/ supine, etc.).                                    forward. Again, a basic knowledge of the normal biodistribu-
                                                                      tion of the radiopharmaceutical and the usual indications for
    If the radiopharmaceutical information is not known, then         performing the study is required. Given these, plus a relatively
the first step in analysis is based on determining the relative       rudimentary understanding of anatomy and physiology, one can
count density of the images. Typically, images of Tc-99m-O4-          "make the finding(s)" with relative certainty. A word of cau-
labeled radiopharmaceuticals have relatively high count den-          tion is in order. There are two common errors that continue to
sity. Many medium- and high-energy isotopes (Indium-111,              cause problems for each new generation of residents. First, it
Gallium-67, Iodine-131, etc.) have lower count density based          is extremely difficult to "see what is not there." Always "take
on longer half lives and therefore lower administered dose.           attendance" and be certain that all organs and structures that
This often results in relatively noisy images. A notable excep-       should be "present" on a given study are visualized with their
tion to this generalization is arterial flow studies performed        normal pattern and relative uptake of radiopharmaceutical.
with Tc-99m-labeled radiopharmaceuticals. Because these               Next, frequently more than one finding of importance will exist.
studies are performed as dynamic acquisitions at a typical rate       It is easy to suffer from "search satisfaction" and quit looking
of 1 to 5 seconds/frame, they too will have a low count density.      for additional abnormalities after one is found. A rigid approach
                                                                      to image analysis is required to prevent both of these errors.
    The number and type of images presented and the type of
acquisition (e.g., PET, SPECT or planar) should be noted. If              When studying dynamic series such as arterial flow studies,
a series of frames are provided, the study is either a dynamic        Tc-99m-labeled red blood cell studies for GI hemorrhage local-
acquisition with the typical timing of seconds or minutes per         ization, renal function images, and so forth, it is important to
frame, or possibly a series of SPECT image slices that will           note the time per frame because you will need to make comments
usually have more counts and appear somewhat smoothed                 concerning the timing of the arrival of the radiopharmaceutical
because of the processing algorithms employed.                        in various structures. This information may be critical to image
                                                                      interpretation and is frequently overlooked by neophytes. Iden-
                                                                      tifying changes from one frame to the next may be difficult. One
                                                                      approach to enhance and speed detection of abnormalities and
                                                                      asymmetries is to study the first frame or two relatively closely
                                                                      and then move directly to the last frame. Direct comparison of
                                                                      early and late images will demonstrate changes between the two
                                                                      most dramatically and will allow you to direct your attention
                                                                      to the appropriate areas on the intervening images and define
                                                                      the correct timing of events. It is helpful to "back through" the
                                                                      images from last to first after identifying any abnormalities on
                                                                      the later images. This approach will rapidly identify with great
                                                                      temporal and anatomic accuracy the exact time of appearance
                                                                      and location of GI hemorrhage, for example.

                                                                          An orderly approach to image analysis for static images is
                                                                      also required, but will vary based on the type of study in ques-
                                                                      tion. Here are specific techniques for some common studies
                                                                      that may be helpful.

                                                                          Skeletal Imaging. Review the images provided with a "top-
                                                                      down" approach, addressing skeletal structures, first on the
                                                                      anterior view, then on the posterior view (Fig. 52.5). Note
                                                                      areas of increased or decreased activity without attaching
                                                                      strong clinical significance to them initially. Always comment
                                                                      on the renal activity that should normally be present and use
                                                                      this as a reminder to evaluate soft tissue activity for abnormal
                                                                      increases, decreases, and asymmetry. This type of approach
                                                                      works well with many of the whole-body imaging studies,
                                                                      although the biodistribution will vary.

                                                                          SPECT Myocardial Perfusion Imaging. Always view the
                                                                      raw data images first, if available, and evaluate for quality
                                                                      control issues, artifacts, and ancillary or incidental findings
                                                                      (breast attenuation, motion, pacemaker artifact, pulmonary
                                                                      uptake, breast tumor, etc.). Always review the exercise data
                                                                      to confirm adequacy of stress or determine what, if any, phar-
                                                                      macologic agent was employed. Next review the short-axis
                                                                      slices, then the vertical long-axis slices, and finally the hori-
                                                                      zontal long-axis slices. Note the presence or absence of areas
                                                                      of decreased perfusion and whether they appear fixed or seem
                                                                      to change between stress and rest images. Note the chamber
                                                                         Chapter 52: Introduction to Nuclear Medicine  1231

FIGURE 52.5. Whole-Body Bone Scan With Tc-99m methylene                      Hepatobiliary Imaging. For this and any other study where
diphosphonate (MDP). The scan demonstrates multiple areas of             flow studies and dynamic imaging are performed, studying the
increased uptake due to diffuse bony metastatic disease in this patient  images in the order in which they were acquired is best: flow
with prostate cancer.                                                    study first, then dynamic images using the approach outlined
                                                                         previously, and finally static images (right lateral or left ante-
size and whether or not it is more dilated at stress than rest.          rior oblique views would be typical) if any. Note the tempo-
Attempt to confirm the presence of any defects in two planes.            ral sequence of the arrival of the arterial bolus in the kidneys,
Then evaluate the wall motion, brightening, and thickening.              spleen, and finally liver if an arterial flow study of the abdomen
Check the end diastolic and end systolic volumes. Evaluate               is provided. With approximately 80% of hepatic blood flow
the stress and rest data including the ejection fractions. Is the        arriving via the portal system, the liver should appear later than
study normal or does it demonstrate reversible changes of                the other organs--if it does not, portal hypertension may be
ischemia? Does it demonstrate a fixed defect consistent with             present. Early flow to the gallbladder fossa implies significant
infarction or hibernating myocardium? Does it demonstrate                inflammation. On the dynamic series, note the appearance of
poststress dilatation or decreased LVEF after stress?                    the early images, then study the later images: Are gallbladder
                                                                         activity and bowel activity present? If so, "back through" the
    Ventilation-Perfusion Imaging for Pulmonary Embolus.                 images and note their first appearance. Is activity visualized in
Always review the chest radiograph or chest CT first, if pro-            the normal sequence of intrahepatic ducts, common hepatic
vided. If not initially available, comment that review of the            duct, gallbladder, common bile duct, and duodenum? Is there
radiograph is essential prior to making a definitive statement           activity in any areas other than expected--stomach, esophagus,
about the likelihood of pulmonary embolus. Review the perfu-             or free spill into the peritoneum? Are there any focal accumula-
sion study in its entirety first. Note the presence of any defects,      tions of labeled bile in the liver, gallbladder fossa, or elsewhere?
their relative sizes (lobar, segmental, and subsegmental), and
their locations. Attempt to confirm the findings in more than                For a situation in which a finding has been made but no
one view. Once the number and location of the defects are                explanation is readily apparent, it is helpful to contemplate
known, attempt to match these defects in the corresponding               the finding while considering a standard list of generic causes
areas on the ventilation study. Summarize the findings and               as well as mechanisms that might lead to the finding. One
segmental anatomy, verbally reciting the number and size of              such generic list uses the mnemonic, VINDICATE as fol-
matched and mismatched defects. State that there is no evi-              lows: Vascular (any cause of increased/decreased blood flow,
dence of pulmonary embolism (normal study) or offer a prob-              collagen vascular diseases); Infectious (always include TB,
ability of pulmonary embolus based on the findings. Then                 Fungal, HIV); Neoplastic (benign or malignant, primary or
determine if another study such as CT angiography may be                 metastatic); Drug-induced (radiopharmaceutical preparation
needed.                                                                  and QC, recent prior radiopharmaceutical administration or
                                                                         contrast study, thyroid hormone ingestion), Idiopathic (sar-
                                                                         coidosis, amyloidosis); Congenital, Artifact (related to patient,
                                                                         clothing, imaging equipment, computer processing, or film
                                                                         processing); Trauma; or Endocrine/metabolic (Paget disease,
                                                                         hyperparathyroidism, etc.).

                                                                             If the physiologic mechanisms of radiopharmaceutical
                                                                         localization are understood, then mechanistic explanations for
                                                                         findings allow another route to a solution. Thus, from a mecha-
                                                                         nistic standpoint, increased activity on a bone scan is caused by
                                                                         either increased delivery of radiopharmaceutical to the bone
                                                                         or increased incorporation due to either increased osteoblas-
                                                                         tic activity or increased dwell time for extraction by normally
                                                                         functioning osteoblasts. Reasons for increased delivery include
                                                                         the following: arterial injection, arteriovenous malforma-
                                                                         tion, infection, tumor, localized inflammation due to trauma,
                                                                         increased use of a limb, neurologic reflex increased flow, and
                                                                         apparent increased uptake with actual reduced uptake in the
                                                                         contralateral body part. Reasons for increased osteoblastic
                                                                         activity include the following: normal growth in epiphyseal
                                                                         bone and enhanced repair in response to fracture, infection,
                                                                         and benign or malignant tumors. Increased dwell time may be
                                                                         caused by constricting clothing, tourniquets, venous obstruc-
                                                                         tion, and lymphatic obstruction.

                                                                             When analyzing a case it is best to follow your initial com-
                                                                         ments concerning the findings with a final image review as you
                                                                         verbally summarize what you believe to be pertinent to the
                                                                         diagnosis. It is not uncommon to realize only as the summary
                                                                         is presented aloud that a specific diagnosis is indicated or that
                                                                         the findings significantly limit the differential diagnosis.

                                                                             The foregoing discussion is not meant to be all-encompass-
                                                                         ing and does not do justice to the entire spectrum of studies
                                                                         and diseases that will be encountered. However, it should pro-
                                                                         vide a starting point for development of one's own approach
                                                                         to image analysis and case-discussion skills. Consider using the
                                                                         images in each of the subsequent chapters as sample unknown
                                                                         cases and attempt to analyze them before reading the captions.
                                                                         This sort of practice will undoubtedly enhance one's ability
                                                                         to take unknown cases with greater confidence and accuracy.
1232  Section Twelve: Nuclear Radiology

                                                                 FIGURE 52.6. Response to Therapy

                                                                 Demonstrated on Whole-Body PET FDG

                                                                 Maximum Intensity Projection Scans. A.

                                                                 Baseline scan shows extensive and metastatic

                                                                 disease in a patient with inflammatory breast

                                                                 cancer. B. Follow-up scan after two cycles of

                                                                 chemotherapy shows excellent early response

                                                                 to therapy which is a predictor of how the

A     B                                                          patient will ultimately respond.

          SECTION OVERVIEW                                       FDG has been shown to be the best and can be predictive of
                                                                 outcome (Fig. 52.6). Molecular processes can now be evalu-
As you will see in the following chapters, nuclear medicine      ated with molecular imaging techniques such as PET FDG,
offers several distinct advantages over traditional anatomi-     C-11 choline, F-18 fluorothymidine, and F-18 dopamine.
cally oriented imaging techniques. There is whole-body detec-    Radiotracer techniques are commonly utilized for stem-cell
tion of disease with bone scans, WBC scans, I-131 metascan,      tracking and in studying genomics and proteomics. Targeted
I-123 MIBG, Ind-111 octreotide, and PET-CT. It can provide       radiotherapy techniques utilize many new forms of molecular
functional evaluation with computer analysis such as with        targeting and more individualized therapies in the near future.
radionuclide ventriculography, gated cardiac SPECT, renal
scintigraphy, gallbladder ejection fraction, gastric emptying,       For this edition of the text, the nuclear medicine section
esophageal transit, and thyroid uptake. Split function analysis  has been thoroughly revised and updated with multiple new
can be done for kidneys, lung, and brain. Diagnostic evalua-     images and current references as needed. The inflammation
tion is done with I-123 for thyroid nodules, PET FDG for pul-    and infection chapter has been completely rewritten. The
monary nodules, diuretic renography for ureteral obstruction,    oncology chapter has been completely rewritten to incorpo-
Tc-RBC for hepatic hemangioma, and Tc-SC for hepatic focal       rate new molecular imaging information. A separate chapter
nodular hyperplasia.                                             on the rapidly expanding area of PET and PET-CT has been
                                                                 added. In every case, the authors have attempted to provide
    Response to therapy is judged with octreotide, MIBG,         clear, concise, current, and useful information. I have no doubt
I-131, and bone scan, but for early response to therapy, PET     that you will find that they have succeeded.
